For the Inventor, By the Inventor

Enter assignee name

Villepinte, France

Guerbet

USPTO Granted Patents = 48

CIPO Patents = 6

EPO Patents = 43

Trademarks = 17

Forward Citations = 129

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Marc Port (18 out of 18 patents)

Olivier Rousseaux (9 out of 13 patents)

Claire Corot (7 out of 7 patents)

4. Martine Cerf (5 out of 5 patents)

5. Myriam Petta (5 out of 5 patents)

6. Caroline Robic (5 out of 6 patents)

7. Giovanni John Jacques Palma (4 out of 17 patents)

8. Alain Chénedé (4 out of 4 patents)

9. Soizic Le Greneur (4 out of 7 patents)

10. Bruno François (4 out of 4 patents)

11. Dominique Meyer (4 out of 24 patents)

12. Emmanuelle Marais (3 out of 3 patents)

13. Stéphanie Louguet (3 out of 3 patents)

14. Maryline Beyler (3 out of 7 patents)

15. Raphaël Tripier (3 out of 9 patents)

Core Competencies:

Gadolinium Complexes

Chelating Ligands

Medical Image Processing

Machine Learning

Lesion Detection

Contrast Medium Formulation

Macrocyclic Ligands

Pharmaceutical Formulations

Nanoparticles

MRI Imaging

Anti-Cancer Agents

Diagnostic Compounds

48 patents: Sort by Forward Citations

1. 12064487 - Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process (2024-08-20),

2. 12012378 - Method for synthesizing 2-bromoglutaric acid diesters (2024-06-18),

3. 11749401 - Seed relabeling for seed-based segmentation of a medical image (2023-09-05),

4. 11694297 - Determining appropriate medical image processing pipeline based on machine learning (2023-07-04),

5. 11688517 - Multiple operating point false positive removal for lesion identification (2023-06-27),

6. 11688065 - Lesion detection artificial intelligence pipeline computing system (2023-06-27),

7. 11688063 - Ensemble machine learning model architecture for lesion detection (2023-06-27),

8. RE49516 - Syringe and method for assembling it (2023-05-01),

9. 11590246 - Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process (2023-02-28),

10. 11472767 - Process for the monotopic preparation of intermediate organo-iodinated compounds for the synthesis of ioversol (2022-10-18),

11. 11426470 - Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched PCTA and synthesis method (2022-08-30),

12. 11370804 - Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process (2022-06-28),

13. 11261166 - Lipophilic macrocyclic ligands, complexes thereof, and uses of same (2022-03-01),

14. 11155553 - Reinforced macrocyclic ligands, complexes thereof, and uses of same (2021-10-26),

15. 11077253 - Syringe (2021-08-03),

Guerbet is a global pharmaceutical company specializing in contrast agents for medical imaging. With a history of over 90 years, Guerbet is a leader in diagnostic solutions and offers a wide range of products for X-ray, MRI, and other imaging techniques.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

48 Patents

#1 in Villepinte

#477 in France

#14,114 in the World

Villepinte, France

Guerbet

Forward Citations = 129

65 inventors:

Marc Port (18 out of 18 patents)

Olivier Rousseaux (9 out of 13 patents)

Claire Corot (7 out of 7 patents)

4. Martine Cerf (5 out of 5 patents)

5. Myriam Petta (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…